Pharmacovigilance in Croatia
How is it with the drug safety system in this Mediterranean country? Read our guide to get a clear picture.
And of course, if you feel you need a local consultant, we’re here for you.
Current status of our Croatian pharmacovigilance services:
LCPPV / EU QPPV in Croatia
AVAILABLE
Easily managed through Tepsivo Platform >
Local Literature Screening
AVAILABLE
Automated monitoring with Tepsivo Literature >
Who is the main PV authority in Croatia?
Other important institutions & industry groups
Some of the most important laws
Essential EU Legislation and EMA Guidlines
Since Croatia is a member of the EU, every Marketing Authorization Holder with a product on the Croatian market needs to follow the European pharmacovigilance legislation and guidelines by EMA (European Medicine Agency).
To navigate through the European regulations, its is useful to know following:
– EMA Pharmacovigilance System Manual
– Directive 2001/83/EC
– Regulation (EC) 726/2004
– Commission Implementing Regulation (EU) 520/2012
Local pharmacovigilance specifics
Useful abbreviations to know
If you want to study local materials about pharmacovigilance in Croatia, following terms will be helpful for you to get familiar with:
EMA (European Medicine Organization)
→ Key part of the EU, dedicated to ensuring the safety and effectiveness of medicines.
EVPM (EudraVigilance post-authorization module)
→ Dedicated to the collection of ICSRs related to all medicinal products authorised in the EEA.
PRAC (Pharmacovigilance Risk Assessment Committee)
→ Committee responsible for assessing and monitoring the safety of human medicines
HALMED (Agencija za lijekove i medicinske proizvode)
→ Agency for Medicinal Products and Medical Devices / Main authority on pharmacovigilance.
Is LCPPV needed or is EU QPPV enough?
How can be adverse events reported in Croatia?
Healthcare professional can use reporting form on this site, via mail, fax or e-mail.
The public can report any suspected adverse reactions directly to the Agency in writing, either through the online application for ADR reporting or by using the form available here. You can also reach out to the marketing authorization holder with your reports.
There is also Rapid alert system, where you can report ADRs by phone.
Local medical journals to screen
Here are few examples of Croatian local literature sources that medical authorization holders should monitor:
CROATIAN MEDICAL JOURNAL (CMJ)
A peer-reviewed diamond open access journal that publishes original research, reviews, and case reports across all fields of medicine.
It is recognized for its commitment to open access, meaning there are no publication fees for authors or charges for readers, making valuable research freely available to the public.
ISSN: 1332-8166
ACTA MEDICA CROATICA
This journal focuses on clinical and experimental medicine, offering a platform for researchers to share their findings with a national and international audience.
It emphasizes the importance of scientific rigor and aims to contribute to the advancement of medical knowledge in Croatia and beyond.
ISSN: 1848-8897
BIOCHEMIA MEDICA
This journal publishes articles related to biochemistry, molecular biology, and clinical chemistry, aiming to bridge the gap between laboratory research and clinical practice.
It provides insights into the biochemical mechanisms underlying various diseases, making it essential reading.
ISSN: 1846-7482
ACTA PHARMACEUTICA
A prominent scientific journal in Croatia that focuses on pharmaceutical sciences, including drug development, pharmacology, and medicinal chemistry.
It publishes original research articles, reviews, and short communications, providing a platform for researchers to share their findings and advancements.
ISSN: 1846-9558
Rather then spending your budget for hours of repetitive manual work to monitor those sources, we recommend to simply automate this task using our Tepsivo Literature solution.
Other interesting resources
Country Public Health / Health System Assessments
Croatia: Country Health Profile 2023
The 2023 edition of “State of Health in the EU: Croatia” provides a comprehensive look at the health landscape in the country, exploring key topics such as overall health status, important health determinants and risk factors, and how the health system is organized and funded.
Publications by HALMED
Brochure: Safe use of medicinal products
This brochure serves as a valuable resource for healthcare professionals, offering guidance on how to detect and report adverse reactions while emphasizing their crucial role in the ongoing monitoring of medicinal product safety and efficacy, in Croatian only.
Here you’ll find all of HALMED’s Annual activity reports since 2010, though sadly all documents are only in Croatian.
Annual Report on Drug Utilisation for 2023 – Croatian Document
There is a list of individual annual reports on the right side, there you can choose whichever year you’re interested in, though once again it is only in Croatian.
Annual Report on Spontaneous Reporting of Adverse Drug Reactions for 2023 – Croatian Document
For the page containing these annual reports applies the same as for the above.
Offical newsletter from HALMED, only in Croatian.
Studies related to pharmacovigilance in Croatia
Curious about how well future healthcare professionals understand pharmacovigilance? This study reveals a significant gap in knowledge among pharmacy, dental, and medical students at the University of Split School of Medicine, highlighting the urgent need for better education on this critical topic—especially as new treatments like COVID-19 vaccines emerge.
This study explores the impact of new EU pharmacovigilance legislation on adverse drug reactions in Croatia, revealing a concerning rise in reports linked to off-label use and overdoses. With data from the HALMED pharmacovigilance database, it uncovers critical insights into how these changes are affecting patient safety and highlights the urgent need for improved monitoring and education in the healthcare system.
Future Healthcare Workers and Ecopharmacovigilance: Where Do We Stand?
This study sheds light on the awareness and practices of Croatian students regarding ecopharmacovigilance (EPV), revealing that they possess a solid knowledge foundation but still require further education on the environmental impacts of drug use. With a particular focus on sustainable prescribing and drug disposal practices, the findings emphasize the urgent need to integrate EPV into healthcare curricula to better prepare future prescribers for their roles in promoting environmental safety.
INTERESTING WEBSITES
HOPAL – Croatian Medicines Verification Organisation
HOPAL’s primary role is to secure the legal supply chain of medicines by verifying the authenticity of medicinal products, thereby enhancing patient safety and combating counterfeit drugs in the Croatian market, read more about what falsified medicine actually is.
Do you need some help with putting the Croatian PV System together? We’re here for you.
And while you’re here…
…consider also our global end-to-end PV solution!
Thanks to the Tepsivo platform, you can get a full pharmacovigilance system in all countries you need – for a fraction of the usual budget.
Tepsivo Oy | Urho Kekkosen katu, 4-6 E, 00 100, Helsinki, Finland | VAT number FI31367614 | contact@tepsivo.com | +358 402 204 698 | Privacy policy













